Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be…
Browsing: PERSEPHONE trial
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- The OJC Episode 25: IASLC World Conference on Lung Cancer Part 1
- Improving immunotherapies for blood cancers: real-time exploration in the tumour
- Targeted delivery of highly toxic anti-cancer drug to brain tumours
- Study shows new treatment pathway to prevent and treat endometrial cancer recurrence
- Study uncovers inhibitory role of ‘Ter cells’ in cancer therapies
- Multiple myeloma: CAR T-cell therapy generates lasting remissions
- COVID-19 vaccination axillary adenopathy detected during breast imaging
- Antihypertensives can decrease bleomycin-induced lung injury
